文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

尿路上皮癌的分子病理学。

Molecular Pathology of Urothelial Carcinoma.

机构信息

Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NW 10065, USA.

Department of Pathology, University of Alabama at Birmingham, University of Alabama at Birmingham School of Medicine, WP Building, Suite P230, 619 19th Street South, Birmingham, AL 35249-7331, USA.

出版信息

Clin Lab Med. 2024 Jun;44(2):181-198. doi: 10.1016/j.cll.2023.08.010.


DOI:10.1016/j.cll.2023.08.010
PMID:38821640
Abstract

Urothelial carcinoma is characterized by the presence of a wide spectrum of histopathologic features and molecular alterations that contribute to its morphologic and genomic heterogeneity. It typically harbors high rates of somatic mutations with considerable genomic and transcriptional complexity and heterogeneity that is reflective of its varied histomorphologic and clinical features. This review provides an update on the recent advances in the molecular characterization and novel molecular taxonomy of urothelial carcinoma and variant histologies.

摘要

尿路上皮癌的特征是存在广泛的组织病理学特征和分子改变,这些特征导致其形态学和基因组异质性。它通常具有高比例的体细胞突变,具有相当大的基因组和转录组复杂性和异质性,反映了其不同的组织形态学和临床特征。本文综述了尿路上皮癌和变异组织学的分子特征和新型分子分类学的最新进展。

相似文献

[1]
Molecular Pathology of Urothelial Carcinoma.

Clin Lab Med. 2024-6

[2]
Molecular Classification of Urothelial Carcinoma.

Surg Pathol Clin. 2025-3

[3]
Molecular Pathology of Urothelial Carcinoma.

Surg Pathol Clin. 2021-9

[4]
Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature.

Histopathology. 2024-11

[5]
Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma.

JCO Precis Oncol. 2025-4

[6]
Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease.

Actas Urol Esp (Engl Ed). 2025-6

[7]
Updates on the Genomics of Bladder Cancer and Novel Molecular Taxonomy.

Adv Anat Pathol. 2020-1

[8]
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder.

Sci Rep. 2025-7-15

[9]
Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review.

Pathol Res Pract. 2019-4-6

[10]
Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review.

Eur Urol. 2014-11-14

引用本文的文献

[1]
Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current Development.

Biomedicines. 2025-1-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索